Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05572229
Title Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma (IFM2021-01)
Acronym IFM2021-01
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital, Lille
Indications
Therapies
Age Groups: senior
Covered Countries FRA


No variant requirements are available.